RecruitingHeart Transplant Rejection
Trifecta-Heart cfDNA-MMDx Study
Eligible age
All ages
Accepts
All genders
Locations
6 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.
Sponsor: University of Alberta
You may qualify if…
- ✓ All heart transplant recipients undergoing a biopsy for clinical indications and protocol biopsies, as determined by their physician or surgeon, will be eligible to enroll in the study.
- ✓ Patients are enrolled based on standard of care biopsies, including surveillance biopsies in high-risk patients, with informed consent.
You may not qualify if…
- ✕ Patients will be excluded from the study if they decline participation
- ✕ Are unable to give informed consent.
- ✕ Recipients of multiple organs.
Where it's recruiting
Source: ClinicalTrials.gov · NCT04707872 · last updated 2026-10-06